Menu
← Oncology Approval Tracker
FDA DECISION ·
Trametinib tablets (first generic)
trametinib · Novugen Oncology
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
First generic of the referenced trametinib tablets. FDA’s first-generics list identifies BRAF V600-defined melanoma, lung cancer, anaplastic thyroid cancer, selected other solid tumors and pediatric low-grade glioma. The applicable indication and combination are product- and formulation-specific.
LAMPGEN ANALYSIS
Why it matters
This approval concerns the tablet presentation of an established MEK inhibitor.
What research teams should watch
Verify the marketed generic’s label, BRAF variant and partner regimen; check for differences between tablets and oral solution.
PRIMARY RECORDS